Morphea in adults and children cohort II: Patients with morphea experience delay in diagnosis and large variation in treatment

Journal of the American Academy of Dermatology

Volumn 67, Issue 5, 2012, Pages 881-889

  Johnson, Weilan ^a   Jacobe, Heidi ^b  

^a PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Drug; Evaluation; Localized scleroderma; Morphea; Sclerosing skin conditions; Specialty; Therapy; Treatment

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL PRACTICE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DELAYED DIAGNOSIS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LOCALIZED SCLERODERMA; MALE; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DELAYED DIAGNOSIS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SCLERODERMA, LOCALIZED; YOUNG ADULT;

EID: 84866996370     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.01.011     Document Type: Article

References (18)

1. Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 2005;52:2873-81
2. Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children: an international study. Rheumatology (Oxford) 2006;45:614-20
3. Weibel L, Laguda B, Atherton D, Harper JI. Misdiagnosis and delay in referral of children with localized scleroderma. Br J Dermatol 2011;165:1308-13
4. Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O'Neil KM. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists. J Rheumatol 2010;37:175-81
5. Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT. Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol 2009;145:545-50
6. Christen-Zaech S, Hakim MD, Afsar FS, Paller AS. Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol 2008;59:385-96
7. Zwischenberger BA, Jacobe HT. A systematic review of morphea treatments and therapeutic algorithm. J Am Acad Dermatol 2011;65:925-41
8. Arkachaisri T, Vilaiyuk S, Torok KS, Medsger TA Jr. Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatology (Oxford) 2010;49:373-81
9. Li SC, Torok KS, Pope E, Stewart KG, Higgins GC, Rabinovich EC, et al. Development of a clinical disease activity measure for juvenile localized scleroderma. Poster No. 2453 presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting; November 5-9, 2011; Chicago, IL
10. Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006;54:440-7
11. El-Mofty M, Zaher H, Bosseila M, Yousef R, Saad B. Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed 2000;16: 43-9
12. Brenner M, Herzinger T, Berking C, Plewig G, Degitz K. Phototherapy and photochemotherapy of sclerosing skin diseases. Photodermatol Photoimmunol Photomed 2005;21: 157-65
13. Kroft EB, Berkhof NJ, van de Kerkhof PC, Gerritsen RM, de Jong EM. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008;59:1017-30
14. Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether-Beck S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997;36: 938-44
15. Kerscher M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998;38: 21-6
16. Camacho NR, Sanchez JE, Martin RF, Gonzalez JR, Sanchez JL. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol 2001;45:697-9
17. Fett N, Werth VP. Update on morphea, part II: outcome measures and treatment. J Am Acad Dermatol 2011;64:231-42; quiz 243-4
18. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006;18:606-13.